We serve Chemical Name:1-(4-Propylphenyl)ethanamine CAS:91339-01-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:1-(4-Propylphenyl)ethanamine
CAS.NO:91339-01-4
Synonyms:1-(4-Propylphenyl)ethanamine
Molecular Formula:C11H17N
Molecular Weight:163.25900
HS Code:2921499090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:248.6ºC at 760 mmHg
Density:0.927g/cm3
Index of Refraction:1.52
PSA:26.02000
Exact Mass:163.13600
LogP:3.35910
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 1-(4-Propylphenyl)ethanamine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-(4-Propylphenyl)ethanamine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-(4-Propylphenyl)ethanamine Use and application,1-(4-Propylphenyl)ethanamine technical grade,usp/ep/jp grade.
Related News: Three more patients have been confirmed infected with coronavirus in South Korea, bringing the country’s total to 15, the South Korean Centers for Disease Control and Prevention (KCDC) announced in a press release. 1-(4-Propylphenyl)ethanamine manufacturer Three more patients have been confirmed infected with coronavirus in South Korea, bringing the country’s total to 15, the South Korean Centers for Disease Control and Prevention (KCDC) announced in a press release. 1-(4-Propylphenyl)ethanamine supplier A key publication in a preclinical model demonstrated rigosertib��s ability to block cellular signaling by targeting RAS effector pathways (Divakar, S.K., et al., 2016: ��A Small Molecule RAS-Mimetic Disrupts RAS Association with Effector Proteins to Block Signaling.�� Cell 165, 643). 1-(4-Propylphenyl)ethanamine vendor Higher-risk MDS is a disease with significant unmet need, and we are pleased to be able to support healthcare professionals seeking access to rigosertib, ahead of its commercial launch,�� said Mark Corbett, EVP, Inceptua Medicines Access. 1-(4-Propylphenyl)ethanamine factory A key publication in a preclinical model demonstrated rigosertib��s ability to block cellular signaling by targeting RAS effector pathways (Divakar, S.K., et al., 2016: ��A Small Molecule RAS-Mimetic Disrupts RAS Association with Effector Proteins to Block Signaling.�� Cell 165, 643).
